{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:19Z","timestamp":1791216499840,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["156911"],"award-info":[{"award-number":["156911"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.imbio.2016.08.014","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T19:22:25Z","timestamp":1473362545000},"page":"967-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-8935","authenticated-orcid":false,"given":"Irma Eloisa","family":"Monroy-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Angeles-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-3488","authenticated-orcid":false,"given":"Rosalinda","family":"Posadas-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Villarreal-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Alvarez-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-1552","authenticated-orcid":false,"given":"Carmina","family":"Flores-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Cardoso-Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Medina-Urrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Gabriel","family":"Ju\u00e1rez-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Posadas-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-5163","authenticated-orcid":false,"given":"Gilberto Vargas","family":"Alarcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2016.08.014_bib0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.atherosclerosis.2015.02.011","article-title":"The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"239","author":"Al Rifai","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imbio.2016.08.014_bib0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF epidemiology task force consensus group. the metabolic syndrome: a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2016.08.014_bib0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome- a world-wide definition: a consensus statement from the international diabetes federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabetes Med."},{"key":"10.1016\/j.imbio.2016.08.014_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","article-title":"Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.imbio.2016.08.014_bib0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tibs.2009.08.003","article-title":"Catalytic and non-catalytic functions of human IIA phospholipase A2","volume":"35","author":"Birts","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.imbio.2016.08.014_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.imbio.2016.08.014_bib0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/dmrr.1082","article-title":"Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City","volume":"26","author":"Cruz","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.imbio.2016.08.014_bib0040","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jc.2009-1222","article-title":"Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease","volume":"95","author":"Dutour","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.imbio.2016.08.014_bib0045","doi-asserted-by":"crossref","first-page":"e41139","DOI":"10.1371\/journal.pone.0041139","article-title":"Functional Analysis of two PLA1G2A variants associated with secretory phospholipase A2-IIA levels","volume":"7","author":"Exeter","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.imbio.2016.08.014_bib0050","first-page":"S4","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"23","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.imbio.2016.08.014_bib0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1573399810602040367","article-title":"Metabolic obesity: the paradox between visceral and subcutaneous fat","volume":"2","author":"Hamdy","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.imbio.2016.08.014_bib0060","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.2337\/db11-1179","article-title":"An inhibitor of phospholipase A2 Group IIA modulates adipocyte signaling and protects against diet induced metabolic syndrome in rats","volume":"61","author":"Iyer","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.imbio.2016.08.014_bib0065","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.1989.00390070054005","article-title":"The deadly quartet upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension","volume":"149","author":"Kaplan","year":"1989","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.imbio.2016.08.014_bib0070","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.100.12.1280","article-title":"Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease","volume":"100","author":"Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.imbio.2016.08.014_bib0075","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ajcn\/48.6.1351","article-title":"Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations","volume":"48","author":"Kvist","year":"1988","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.imbio.2016.08.014_bib0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(02)00371-4","article-title":"Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes","volume":"166","author":"Leinonen","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imbio.2016.08.014_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2796.2004.01350.x","article-title":"Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes","volume":"256","author":"Leinonen","year":"2004","journal-title":"J. Int. Med."},{"key":"10.1016\/j.imbio.2016.08.014_bib0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabres.2009.06.020","article-title":"Metabolic syndrome defined by IDF and AHA\/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO","volume":"85","author":"Ma","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.imbio.2016.08.014_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543770903463905","article-title":"Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases","volume":"20","author":"Magrioti","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.imbio.2016.08.014_bib0100","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/ATVBAHA.107.139352","article-title":"Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study","volume":"27","author":"Mallat","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.imbio.2016.08.014_bib0105","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/ATVBAHA.110.204669","article-title":"Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study","volume":"30","author":"Mattsson","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.imbio.2016.08.014_bib0110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1148\/radiology.192.3.8058924","article-title":"Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation","volume":"192","author":"Mautner","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.imbio.2016.08.014_bib0115","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1111\/j.1572-0241.2008.02188.x","article-title":"Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study","volume":"103","author":"McKimmie","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.imbio.2016.08.014_bib0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1160\/TH13-01-0075","article-title":"Thrombosis in central obesity and metabolic Syndrome: mechanisms and epidemiology","volume":"110","author":"Morange","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.imbio.2016.08.014_bib0125","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988: Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.imbio.2016.08.014_bib0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3904\/kjim.2015.30.1.73","article-title":"Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score","volume":"30","author":"Seo","year":"2015","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.imbio.2016.08.014_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","article-title":"The expanding superfamily of phospholipase A(2) enzymes: classification and characterization","volume":"1488","author":"Six","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imbio.2016.08.014_bib0140","unstructured":"The Metabolic Syndrome, WHO. criteria. www.staff.ncl.ac.uk\/Philip.home\/who_dgm.pdf (accessed 24.03.09.)."},{"key":"10.1016\/j.imbio.2016.08.014_bib0145","doi-asserted-by":"crossref","first-page":"10077","DOI":"10.1074\/jbc.275.14.10077","article-title":"Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I","volume":"275","author":"Tietge","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2016.08.014_bib0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2005-0873","article-title":"Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity","volume":"91","author":"Varastehpour","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.imbio.2016.08.014_bib0155","doi-asserted-by":"crossref","first-page":"e49285","DOI":"10.1371\/journal.pone.0049285","article-title":"The ABCA1 gene R230C variant is associated with decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study","volume":"7","author":"Villarreal-Molina","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.imbio.2016.08.014_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1098-3597(05)80065-1","article-title":"The metabolic basis of atherogenic dyslipidemia","volume":"7","author":"Vinik","year":"2005","journal-title":"Clin. Cornerstone"},{"key":"10.1016\/j.imbio.2016.08.014_bib0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/ddi453","article-title":"Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study","volume":"15","author":"Wootton","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.imbio.2016.08.014_bib0170","first-page":"31","article-title":"A new IDF worldwide definition of the metabolic syndrome: the rationale and the results","volume":"50","author":"Zimmet","year":"2005","journal-title":"Diabetes Voice"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298516303618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298516303618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:43:40Z","timestamp":1759250620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298516303618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0171298516303618"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2016.08.014","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2016.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}